Gendering Drugs Feminist Studies of Pharmaceuticals

Please use this identifier to cite or link to this item: 192.168.6.56/handle/123456789/20016

Full metadata record

DC Field	Value	Language
dc.contributor.author	Johnson, Ericka	-
dc.date.accessioned	2018-11-09T11:31:43Z	-
dc.date.available	2018-11-09T11:31:43Z	-
dc.date.issued	2017	-
dc.identifier.isbn	978-3-319-51487-1	-
dc.identifier.uri	http://10.6.20.12:80/handle/123456789/20016	-
dc.description	The title of this volume, Gendering Drugs, is a double entendre. It speaks to the idea that pharmaceuticals can be gendered—perceived as being masculine or feminine, for men or women—by the bodies and symptoms they are supposed to treat, by market forces and marketing campaigns, and by user demographics. Just think of the infamous little blue pill, Viagra, and the attempts to sell a pink version of the same blockbuster drug (Cacchioni 2015). The other meaning in the title suggests the ways that pharmaceuticals create gendered subjectivities for us, the users. Pharmaceuticals can articulate gendered values, norms, behaviors and expectations that we as users (or misusers, or resisters) must respond to in some way. Drugs can be gendered and they can engender us.	-
dc.language	en	en_US
dc.language.iso	en	en_US
dc.publisher	Palgrave Macmillan	en_US
dc.subject	Gendering Drugs	en_US
dc.title	Gendering Drugs Feminist Studies of Pharmaceuticals	en_US
dc.type	Book	en_US
Appears in Collections:	Gender

Files in This Item:

File	Description	Size	Format
Ericka Johnson.pdf		2.22 MB	Adobe PDF	View/Open